Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Psychoactive Substances
New Psychoactive Substances – Designer Benzodiazepines
ISSUP Pakistan present their Webinar on New Psychoactive Substances – Designer Benzodiazepines.
Psychological factors and the use of psychoactive substances in relation to sexual orientation: A study on Israeli young adults.
In the context of sexual minorities and the distress they may experience, recent years have witnessed a trend emphasizing the idea that protective factors may curb risk behaviors, while stressing that not all sexual minorities do experience...
The need to establish the first safe consumption site in Israel
The paper presents the case for establishment of safe consumption sites (SCS) in Israel. An SCS, also known as a drug consumption room (DCR), provides a safe and medically supervised setting for people who inject drugs (PWID) to use drugs...
ISSUP Poster for Lisbon Addictions 2022: Study on substance use and the role of families in Kazakhstan, Pakistan and Ukraine
The fourth European Conference on Addictive Behaviours and Dependencies took place in Lisbon from 23-25 November 2022. Under the overarching theme of Global Addictions, LxAddictions22 showcased cutting-edge research to help characterise...
The risk matrix: Drug-related deaths in prisons in England and Wales, 2015–2020
This article explores the factors contributing to drug-related deaths in English and Welsh prisons between 2015 and 2020.
Inter-glam Bursary Award for Pakistani Delegate Participation in Lisbon Addictions
During the second last month of 2022, November 22-24 an international conference was held successfully at the Lisbon Congress Center in Portugal with the collaboration of SICAD, EMCDDA and the Portuguese Directorate. Organized by Clinic in...
HIV and Substance Use: Reading List
World AIDS Day takes place in December each year. This reading list contains a list of research, publications and resources for practitioners relating to HIV/Aids. We also have a network dedicated to HIV and HCV where you can find a...
Responding to drug-related infectious diseases: EMCDDA mini guide
Sharing drug injecting equipment increases the risk of transmitting and acquiring blood-borne infections, such as HIV and hepatitis B and C. While hepatitis C is the most prevalent blood-borne viral infection among people who inject drugs...
HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs
Since the beginning of the HIV epidemic, the focus on HIV prevention, treatment and care among people who use drugs has concentrated on the needs of people who inject drugs, and mainly on those who inject opioids. However, data show that...
The Canadian Community Epidemiology Network on Drug Use (CCENDU) Bulletin: An Update on Stimulant Use and Related Harms in Canada and the United States
The Canadian Community Epidemiology Network on Drug Use (CCENDU) is a pan-Canadian network of community partners co-ordinated by the Canadian Centre on Substance Use and Addiction (CCSA). The network has sites in British Columbia, Manitoba...